Completed study

Official Study Title
FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019 (COVID-19): A randomized controlled trial (FERMIN trial)

Brief Description
FERMIN is a randomized clinical trial aiming to assess the clinical impact of fenofibrate to improve clinical outcomes in patients with COVID-19.

Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites:  8 sites in Greece
Actual enrolment: 200 participants

EudraCT number: 2021-000843-33
National Organization for Medicines Approval: IS026-21
National Ethics Committee Approval: 20/21

Study Start: April 2021
Study Completion: April 2022

Condition/Disease studied: COVID-19
Keywords: COVID-19

Related publications